
Opinion|Videos|June 25, 2024
Empowering Patients: Understanding New Treatments and Long-Term Considerations with Fresh Approaches and FDA Endorsements
Author(s)Kristine Kucera, PA-C, MPAS, DHS , Mickey Bryson
Mickey Bryson recounts how Kristine Kucera, PA-C, MPAS, DHS, introduced a new medication and shared trial data with him, empowering him to make an informed decision about trying the new treatment.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Kyowa Kirin Takes Full Control of Rocatinlimab Program
2
Dermatology Times January 2026 Recap
3
Phase 2 TYK2 Inhibition Shows Promise in AD
4
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
5











